Published in Drug Law Weekly, November 28th, 2006
Gross profit on product revenue for the second quarter of fiscal year 2007 was $1,765,000 (66%) compared to $1,844,000 (68%) for the second quarter of fiscal year 2006.
Operating expenses for the second quarter of fiscal year 2007 were $3,961,000 compared to $3,480,000 for the same period in fiscal year 2006. This increase in operating expenses...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.